AI Verdict
PCOR has stronger fundamentals based on our AI analysis.
PCOR vs PBSV Fundamental Comparison
| Metric | PCOR | PBSV |
|---|---|---|
| Revenue | $1.3B | $2.3M |
| Net Income | $-100.8M | $32,860.0 |
| Net Margin | -7.6% | 1.4% |
| ROE | -8.0% | 0.3% |
| ROA | -4.5% | 0.2% |
| Current Ratio | 1.32x | 4.03x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-0.67 | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PCOR vs PBSV: Frequently Asked Questions
Is PCOR or PBSV a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PCOR has stronger fundamentals. PCOR is rated BUY (68% confidence) while PBSV is rated SELL (78% confidence). This is not investment advice.
How does PCOR compare to PBSV fundamentally?
PROCORE TECHNOLOGIES, INC. has ROE of -8.0% vs Pharma-Bio Serv, Inc.'s 0.3%. Net margins are -7.6% vs 1.4% respectively.
Which stock pays higher dividends, PCOR or PBSV?
PCOR has a dividend yield of N/A or no dividend while PBSV has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PCOR or PBSV for long term?
For long-term investing, consider that PCOR has BUY rating with 68% confidence, while PBSV has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PCOR vs PBSV?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PCOR vs PBSV, the AI consensus favors PCOR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.